Search This Blog

Monday, January 24, 2022

ResMed gets 2 upgrades

 To Overweight from Neutral at JP Morgan

To Neutral from Underperform at B of A; target to $250 from $239

https://finviz.com/quote.ashx?t=RMD

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)